Key result
The CK-MB-HDL ratio demonstrated high diagnostic accuracy for discriminating between non-coronary chest pain and unstable angina, yielding an AUC of 0.97.
Why the study?
Lipid abnormalities increase CHD risk, prompting the verification and evaluation of the diagnostic value of cardiac enzymes-lipid profile ratios for diagnosing CHD patients.
Does the cardiac enzymes-lipid profile ratio improve diagnostic accuracy for coronary heart disease in chest pain patients?
Observational (n=400)
Does the cardiac enzymes-lipid profile ratio improve diagnostic accuracy for coronary heart disease in chest pain patients?
Answers are grounded in this paper and cite their sources.
May enhance chest pain triage accuracy; extends integrated biomarker diagnostics in acute coronary evaluation.
Background: Lipid abnormalities increase Coronary Heart Disease (CHD) risk. Our developed indexes 1,2 were reported in scientific Journals. Here, we verified and evaluated the cardiac enzymes-lipid profile ratio's diagnostic value for diagnosing CHD patients. Methods: Lipid profiles and cardiac enzymes were estimated in all chest pain patients. The area under the receiver-operating characteristic curve (AUC) was used to evaluate the markers' diagnostic accuracy. Results: There were varieties of significant differences (P < 0.01- P < 0.0001) of Creatine Kinase MB (CK-MB) - lipid profile ratio and Troponin I-lipid profile ratio within the groups of chest pain patients. For discriminating between Non-Coronary Chest Pain (NCCP) and Stable Angina (SA) groups, the AUCs were the greatest for CK-MB- High-density Lipoprotein (HDL) ratio (0.62) and for Troponin I-HDL (0.62). Moreover, for discriminating between NCCP and Unstable Angina (UA) groups, the AUC was the greatest for CK-MB-HDL ratio (0.97). Also, for discriminating between NCCP and Acute Myocardial Infarction (AMI) groups, the AUC was the greatest for index 2 (0.99). Similarly, for discriminating between SA and UA groups, the AUC was the greatest for CK-MB-HDL ratio (0.90). For discriminating between SA and AMI groups, the AUC was the greatest for index 2 (0.97). Finally, for discriminating between UA and AMI groups, the AUC was the greatest for index 2 (0.78). Conclusion: Independent CK-MB-HDL ratio can be used as a good and simple index for diagnosing CHD in chest pain patients and discriminating between the different groups of these patients
No takes yet. Share an insight, caveat, or question.
Kadry et al. (2021) conducted an observational in Coronary Heart Disease (n=400). CK-MB-HDL ratio vs. Non-Coronary Chest Pain (NCCP) was evaluated on Diagnostic accuracy (AUC) for discriminating between Non-Coronary Chest Pain and Unstable Angina (AUC 0.97, 95% CI 0.924-0.999, p=<0.0001). The CK-MB-HDL ratio demonstrated high diagnostic accuracy for discriminating between non-coronary chest pain and unstable angina, yielding an AUC of 0.97.
Synapse has enriched 10 related papers. Consider them for comparative context: